Case Report on Idiopathic Purpura Fulminans in an Infant
Author Information
Author(s): Macheret Fima, Pundi Kavitha N, Broomall Eileen M, Davis Dawn M, Rodriguez Vilmarie, Brands Chad K
Primary Institution: Mayo Medical School
Hypothesis
Can empiric anti-coagulation effectively manage idiopathic purpura fulminans in infants without biochemical evidence of protein C or S deficiency?
Conclusion
The case highlights the need for rapid diagnosis and empiric anti-coagulation in infants with suspected idiopathic purpura fulminans to prevent severe outcomes.
Supporting Evidence
- The infant presented with necrotic eschars and was diagnosed through skin biopsy.
- Treatment with anti-coagulation was initiated due to the recurrence of lesions upon discontinuation.
- The patient required long-term anti-coagulation to manage his condition.
Takeaway
This study is about a baby who had a rare skin condition that caused serious sores. The doctors found that giving him blood thinners helped him get better.
Methodology
The infant was treated with low-molecular-weight heparin and transitioned to warfarin after diagnosis through skin biopsy.
Limitations
The study is based on a single case, limiting generalizability.
Participant Demographics
A six-month-old Caucasian male infant.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website